| scholarly article | Q13442814 |
| P50 | author | Theresa Falls | Q60683608 |
| David F Stojdl | Q115626236 | ||
| P2093 | author name string | Kristina Allan | |
| Tommy Alain | |||
| Douglas J Mahoney | |||
| Ahmed Aman | |||
| Rima Al-Awar | |||
| Charles Lefebvre | |||
| Methvin Isaac | |||
| Stephen Baird | |||
| David Uehling | |||
| Brian Wilson | |||
| Nelson Pearce | |||
| Ahmed Mamai | |||
| Jan Brun | |||
| Cina A Sanaei | |||
| Mikael Prakesh | |||
| Susanna Grönberg | |||
| P433 | issue | 4 | |
| P921 | main subject | oncolytic virus | Q1560099 |
| cell death | Q2383867 | ||
| P304 | page(s) | 443-456 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death | |
| P478 | volume | 20 |
| Q51038542 | 5,7,3',4'-Tetramethoxyflavone protects chondrocytes from ER stress-induced apoptosis through regulation of the IRE1α pathway |
| Q36053744 | Acridine Derivatives as Inhibitors of the IRE1α-XBP1 Pathway Are Cytotoxic to Human Multiple Myeloma. |
| Q36582828 | Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1 |
| Q26767209 | Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy |
| Q26778533 | Cancer Microenvironment and Endoplasmic Reticulum Stress Response |
| Q36439726 | Cell-based genomic screening: elucidating virus-host interactions |
| Q34594638 | Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection. |
| Q36525146 | Cordyceps militaris and mycelial fermentation induced apoptosis and autophagy of human glioblastoma cells |
| Q37381745 | Danger signalling during cancer cell death: origins, plasticity and regulation. |
| Q47269065 | Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1. |
| Q59809101 | Development and applications of oncolytic Maraba virus vaccines |
| Q39441238 | Emerging Role of the Unfolded Protein Response in Tumor Immunosurveillance. |
| Q38385700 | Endoplasmic reticulum quality control in cancer: Friend or foe. |
| Q34376123 | Endoplasmic reticulum stress and cancer |
| Q42014579 | Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51 |
| Q47779811 | Fighting Fire with Fire: Rewiring Tumor Cells for Oncolytic Virotherapy |
| Q26822694 | From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer |
| Q38061354 | Functional genomic screening to enhance oncolytic virotherapy |
| Q59349289 | Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy |
| Q26823674 | High-throughput screening to enhance oncolytic virus immunotherapy |
| Q36040437 | IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis |
| Q34408794 | Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. |
| Q36891318 | Infectio: a Generic Framework for Computational Simulation of Virus Transmission between Cells. |
| Q39913549 | Interfering with tumor pathways that augment viral oncolysis |
| Q50131857 | Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors. |
| Q39126546 | Involvement of unfolded protein response, p53 and Akt in modulation of porcine reproductive and respiratory syndrome virus-mediated JNK activation |
| Q45325393 | Liver cancer: Sensitizing hepatocellular carcinoma to oncolytic virus therapy. |
| Q37562080 | Maraba virus as a potent oncolytic vaccine vector |
| Q38069953 | Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses |
| Q42283940 | Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity. |
| Q38848223 | Oncolytic Immunotherapy for Treatment of Cancer |
| Q41699675 | Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer |
| Q28081685 | Oncolytic parvoviruses: from basic virology to clinical applications |
| Q27025600 | Oncolytic viruses as anticancer vaccines |
| Q21245758 | Oncolytic viruses as therapeutic cancer vaccines |
| Q52688581 | Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy |
| Q58416976 | Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials |
| Q37062074 | Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer |
| Q40071126 | Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms. |
| Q38985173 | Snapshot: implications for melatonin in endoplasmic reticulum homeostasis. |
| Q27640568 | Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors |
| Q37181377 | Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy |
| Q40072916 | Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma |
| Q38489729 | Targeting the IRE1α-XBP1 branch of the unfolded protein response in human diseases |
| Q37285838 | The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies |
| Q38241996 | The impact of the endoplasmic reticulum protein-folding environment on cancer development |
| Q24596804 | The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule |
| Q36288329 | The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd |
| Q38036471 | The use of oncolytic viruses to overcome lung cancer drug resistance |
| Q51846287 | Tumor Restrictions to Oncolytic Virus |
| Q59350015 | Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens |
| Q98902950 | Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses |
| Q38261256 | Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. |
| Q56991805 | Visualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital Microscopy |
| Q33926690 | XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway |
Search more.